Nonalcoholic Fatty Liver Disease [dsyn]    
overview [inpr]    
DIAGNOSIS [fndg]    
pathogenesis [ftcn]    
treatment [ftcn]    
considerations [fndg]    
Global [spco]    
OBESITY [dsyn]    
LIVER INJURY [inpo]    
NAFLD [dsyn]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Estimated [qnco]    
ADULT [aggp]    
Populations [qnco]    
Developed Countries [qlco]    
NAFLD [dsyn]    
quality data [qlco]    
Currently [tmco]    
Lacking [qlco]    
condition [dsyn]    
Increasing [ftcn]    
Children [aggp]    
NAFLD [dsyn]    
Suspected [qlco]    
Available [ftcn]    
Simple [qlco]    
Clinical Signs [fndg]    
Biochemistry [ocdi]    
Consistent [idcn]    
INSULIN RESISTANCE [patf]    
SMALL [qnco]    
NAFLD [dsyn]    
Often [tmco]    
considered [idcn]    
Benign condition [fndg]    
progress [ftcn]    
SEVERE [qlco]    
Stages [qlco]    
LIVER DISEASE [dsyn]    
Including [ftcn]    
Nonalcoholic Steatohepatitis [dsyn]    
FIBROSIS [patf]    
CIRRHOSIS [dsyn]    
Occasionally [tmco]    
HEPATOCELLULAR CARCINOMA [neop]    
NAFLD [dsyn]    
Increased [qnco]    
Type II Diabetes [dsyn]    
INSULIN RESISTANCE [patf]    
Dyslipidemia [dsyn]    
Dysglycemia [dsyn]    
histologic examination [lbpr]    
Liver Tissue [bpoc]    
Proven [qlco]    
Simple [qlco]    
Steatosis [patf]    
condition [dsyn]    
Likely [qlco]    
progress [ftcn]    
CIRRHOSIS [dsyn]    
Identification [menp]    
Imaging Technique [diap]    
Non-invasive [ftcn]    
Marker [clna]    
Much [qnco]    
Larger [qnco]    
CLINICAL TRIALS [resa]    
Clinical Assessment [hlca]    
CASE SERIES [resa]    
Studies, Pilot [resa]    
Lifestyle [socb]    
Advice [hlca]    
Medications [phsu]    
Improvement [cnce]    
LIVER [bpoc]    
Histology [bmod]    
SERUM [bdsu]    
Robust [qlco]    
Randomized [resa]    
Controlled Study [resa]    
Needed [qlco]    
Cost Benefit [qnco]    
RATIO [qnco]    
new therapy [fndg]    
Evaluated [hlca]    
Advocate [ocdi]    
